Valo Therapeutics, developer of immunotherapy platforms for cancer and infectious diseases, has announced the acquisition of an innovative tumor ‘fingerprint’ i 25 July 2022
Gene expression company Syros Pharmaceuticals is to acquire TYME Technologies in a deal that values the oncology-focused biotech at around $60 million. 5 July 2022
UK-based biotech Roquefort Therapeutics is to acquire Oncogeni in an all-share transaction which sources value at around £4 million ($4.9 million). 22 June 2022
USA-based Insmed (NASDAQ CM: INSM) is a biopharmaceutical company on the development and commercialization of novel, targeted inhaled therapies for patients with serious rare diseases.
Sign up to receive email updates Join industry leaders for a daily roundup of biotech & pharma news